Abstract
A joint research team led by Professor Eijiro Miyako of the Japan Advanced Institute of Science and Technology (JAIST), in collaboration with Daiichi Sankyo Co., Ltd. and University of Tsukuba, has developed an immune-independent bacterial cancer therapy using a novel microbial consortium called AUN.
Key Data
-
Publication Date05 August 2025
-
Primary AuthorJapan Advanced Institute
-
SourceMedical Xpress
-
LanguageEnglish
Click below to visit original source: